Studying AGEs and muscle loss in obesity and diabetes
Part of Brain & nervous system, Hormones & metabolism clinical trials.
This study is looking at how certain sugar-related proteins (called AGEs) might be linked to muscle loss in people with obesity and type 2 diabetes. It aims to understand why muscle wasting happens in this condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have obesity and type 2 diabetes that is well-controlled (HbA1c under 7.5%), or you have lipodystrophy.
- You do not have other causes of obesity like Cushing's syndrome, hypothyroidism, Prader-Willi syndrome, or Down syndrome.
- You do not have inflammatory bowel disease (IBD) or cancer.
- You are not pregnant or planning to become pregnant during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new approach to treat sarcopenia (age-related muscle loss) by targeting a protein called HIF-1α. It compares older adults with sarcopenia to younger adults without it, all of whom are having hip or knee surgery.
This study looks at muscle loss (sarcopenia) in people 60 and older who have had type 2 diabetes for at least 5 years. It aims to understand how diabetes might affect muscle health.
This study looks at sarcopenia, which is age-related loss of muscle, in people with certain types of heart failure or in people with stable type 2 diabetes but no symptoms. The goal is to better understand muscle changes and what might help people stay stronger.
This study looks at whether better blood sugar control changes levels of a hormone called irisin in people with type 2 diabetes and obesity, including those with or without age-related muscle loss (sarcopenia). Your results may help researchers understand the body’s response to diabetes and could guide future treatment ideas.
This trial looks at how muscle health is affected by metabolic or hormone disorders, aiming to find better markers for muscle loss called sarcopenia.
This study looks at the bacteria in your gut (the microbiome) to understand how they relate to obesity and muscle loss. Researchers will collect stool samples to analyze the gut bacteria, which may help find new ways to treat metabolic diseases.
Hear when a new Sarcopenia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.